Annual Results 2020

2020 was an extraordinary year for the entire world, characterized by the fight against the COVID-19 pandemic. As a research-driven biopharmaceutical company, we have joined forces in the search for treatment options against the disease. At the same time, we continue our daily work to find innovative solutions in our three business areas: Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing. Thanks to our strong commitment and investments into Research and Development, we can further accelerate the development of new medicines which will transform the lives of humans and animals around the world.